Although no difference in the expression of CD38 within total B lymphocytes was observed between SSc and HC, the finding of lower levels in the subgroups treated with immunosuppressive drugs may indicate some effect of these therapeutics on humoral adaptive immunity (16). This evidence concerns the gene CD38 and systemic sclerosis.